KAITLIB FE Drug Patent Profile
When do Kaitlib Fe patents expire, and what generic alternatives are available?
Kaitlib Fe is a drug marketed by Lupin and is included in one NDA.
The generic ingredient in KAITLIB FE is ethinyl estradiol; norethindrone. There is one drug master file entry for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for KAITLIB FE?
- What are the global sales for KAITLIB FE?
- What is Average Wholesale Price for KAITLIB FE?
Summary for KAITLIB FE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 6 |
| Patent Applications: | 223 |
| DailyMed Link: | KAITLIB FE at DailyMed |
US Patents and Regulatory Information for KAITLIB FE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lupin | KAITLIB FE | ethinyl estradiol; norethindrone | TABLET, CHEWABLE;ORAL | 203448-001 | Dec 17, 2015 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
